Cargando…

Normalization cancer immunotherapy: blocking Siglec-15!

Detalles Bibliográficos
Autores principales: Cao, Guangchao, Xiao, Zhiqiang, Yin, Zhinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473001/
https://www.ncbi.nlm.nih.gov/pubmed/31016034
http://dx.doi.org/10.1038/s41392-019-0045-x
_version_ 1783412337060872192
author Cao, Guangchao
Xiao, Zhiqiang
Yin, Zhinan
author_facet Cao, Guangchao
Xiao, Zhiqiang
Yin, Zhinan
author_sort Cao, Guangchao
collection PubMed
description
format Online
Article
Text
id pubmed-6473001
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64730012019-04-23 Normalization cancer immunotherapy: blocking Siglec-15! Cao, Guangchao Xiao, Zhiqiang Yin, Zhinan Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2019-04-19 /pmc/articles/PMC6473001/ /pubmed/31016034 http://dx.doi.org/10.1038/s41392-019-0045-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Highlight
Cao, Guangchao
Xiao, Zhiqiang
Yin, Zhinan
Normalization cancer immunotherapy: blocking Siglec-15!
title Normalization cancer immunotherapy: blocking Siglec-15!
title_full Normalization cancer immunotherapy: blocking Siglec-15!
title_fullStr Normalization cancer immunotherapy: blocking Siglec-15!
title_full_unstemmed Normalization cancer immunotherapy: blocking Siglec-15!
title_short Normalization cancer immunotherapy: blocking Siglec-15!
title_sort normalization cancer immunotherapy: blocking siglec-15!
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473001/
https://www.ncbi.nlm.nih.gov/pubmed/31016034
http://dx.doi.org/10.1038/s41392-019-0045-x
work_keys_str_mv AT caoguangchao normalizationcancerimmunotherapyblockingsiglec15
AT xiaozhiqiang normalizationcancerimmunotherapyblockingsiglec15
AT yinzhinan normalizationcancerimmunotherapyblockingsiglec15